Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing.

Nazila JamshidiAkshay AthavaleChristopher TremontiCatherine McDonaldShanmugam BanukumarSantiago VazquezNatasha LuquinMarina J Santiago Bridin Patricia Murnion

Published in: British journal of clinical pharmacology (2022)

Interpretation of qualitative urine drug screens to assess adherence in OAT is complex. Poor adherence with treatment cannot be assumed in patients returning a negative qualitative GC-MS urine drug screen.

Keyphrases

high throughput
end stage renal disease
systematic review
chronic kidney disease
ejection fraction
newly diagnosed
metabolic syndrome
prognostic factors
genome wide
glycemic control
peritoneal dialysis